Bioactivity:

Atuveciclib is a potent and highly selective, oral P-TEFb/CDK9 inhibitor which supresses CDK9/CycT1 with an IC50 of 13 nM. Atuveciclib Racemate (BAY-1143572 Racemate) is the racemate mixture of Atuveciclib.

CAS nr:

1414943-88-6

Purity:

98%

Molecular Weight:

387,43

SMILES:

N=S(CC1=CC(NC2=NC(C3=CC=C(F)C=C3OC)=NC=N2)=CC=C1)(C)=O

Formula:

C18H18FN5O2S

Pathway:

Cell Cycle/Checkpoint

Target:

CDK